RIVAROXABAN
LUPIN · RIVAROXABAN
Open FDA's page for this record- Application number
- ANDA208555
- Sponsor name
- LUPIN
- Submissions
- Submission type
- ORIG
- Submission number
- 2
- Submission status
- AP
- Submission status date
- 20250514
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20250303
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 003
- Reference drug
- No
- Brand name
- RIVAROXABAN
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- RIVAROXABAN
- Strength
- 15MG
- Product number
- 001
- Reference drug
- No
- Brand name
- RIVAROXABAN
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- RIVAROXABAN
- Strength
- 2.5MG
- Product number
- 004
- Reference drug
- No
- Brand name
- RIVAROXABAN
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- RIVAROXABAN
- Strength
- 20MG
- Product number
- 002
- Reference drug
- No
- Brand name
- RIVAROXABAN
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- RIVAROXABAN
- Strength
- 10MG
- Harmonized identifiers (openFDA)
- Application number
- ANDA208555
- Brand name
- RIVAROXABAN
- Generic name
- RIVAROXABAN
- Manufacturer name
- Lupin Pharmaceuticals, Inc.
- Product NDC
- 68180-709
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- RIVAROXABAN
- RxCUI
- 2059015
- SPL ID
- 310f0bf6-9b0f-441b-afd7-b9a0f7905395
- SPL set ID
- 702fed3e-ae25-49ba-98cc-562e0e244214
- Package NDC
- 68180-709-09, 68180-709-06
- Nui
- N0000175635, N0000175637
- Pharm class moa
- Factor Xa Inhibitors [MoA]
- Pharm class epc
- Factor Xa Inhibitor [EPC]
- UNII
- 9NDF7JZ4M3
